amiodarone (relative contraindication due to bradycardia risk)
E1242137
UNEXPLORED
Amiodarone is a potent class III antiarrhythmic medication used to treat serious ventricular and supraventricular arrhythmias, notable for its complex pharmacokinetics and risk of multiple organ toxicities.
All labels observed (1)
| Label | Occurrences |
|---|---|
| amiodarone (relative contraindication due to bradycardia risk) canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T16946220 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: amiodarone (relative contraindication due to bradycardia risk) Context triple: [Sovaldi, contraindicatedWith, amiodarone (relative contraindication due to bradycardia risk)]
-
A.
RE-LY trial
The RE-LY trial was a large, pivotal clinical study that compared the efficacy and safety of the oral anticoagulant dabigatran with warfarin for stroke prevention in patients with atrial fibrillation.
-
B.
Entresto
Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
-
C.
Verapaz
Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
-
D.
Brilinta
Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
-
E.
Aritimi
Aritimi is an Etruscan goddess associated with the wilderness, hunting, and the moon, closely related to the Greek Artemis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: amiodarone (relative contraindication due to bradycardia risk) Target entity description: Amiodarone is a potent class III antiarrhythmic medication used to treat serious ventricular and supraventricular arrhythmias, notable for its complex pharmacokinetics and risk of multiple organ toxicities.
-
A.
RE-LY trial
The RE-LY trial was a large, pivotal clinical study that compared the efficacy and safety of the oral anticoagulant dabigatran with warfarin for stroke prevention in patients with atrial fibrillation.
-
B.
Entresto
Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
-
C.
Verapaz
Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
-
D.
Brilinta
Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
-
E.
Aritimi
Aritimi is an Etruscan goddess associated with the wilderness, hunting, and the moon, closely related to the Greek Artemis.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.